PDE4 inhibition in inflammatory lung disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1414, 2003-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease

By Spina D.

Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. : 2575-2594

Adis International

Access to resources Recommend Favorite

PDE4 inhibitors and chronic obstructive pulmonary disease

By Wolda S.L.

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 309-319

Informa Healthcare

Access to resources Recommend Favorite

The Potential of PDE4 Inhibitors in Respiratory Disease

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 231-236

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs

Current Pharmaceutical Design, Vol. 8, Iss. 14, 2002-06 ,pp. : 1255-1296

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M. Gristwood R.W. Cooper N. Hellewell P.G.

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite